pensyarah universiti
pusat kajian diagnostik, teraputik & penyiasatan (codtis)
nurulamin@ukm.edu.my
Kluster Kepakaran/ Cluster of Expertise :
Kesihatan dan Perubatan Termaju,
Biografi/ Biography :
I am a Senior Lecturer (Biomedical Science Program) & Researcher (CODTIS) at the Faculty of Health Sciences, UKM. My research focuses on discovering novel biomarkers using mass spectrometry-based technologies in glycomics and glycoproteomics as well as immunoassay technology, particularly for congenital disorders of glycosylation (CDG) and glycosylation-related diseases like cancer. As a Medical Lab Scientist (MLS), I specialize in Quality Assurance (QA), Quality Control (QC), and managing specialized diagnostics in clinical biochemistry laboratory.
nurulamin abu bakar, nurul izzati hamzan, siti nurwani ahmad ridzuan, izatus shima taib, zariyantey abdul hamid, anasufiza habib, noor hafizah hassan. (2026). multi-marker evaluation of creatinine, cystatin c and ß2-microglobulin for gfr estimation in stage 3–4 ckd using the 2021 ckd-epi equations. - international journal of molecular sciences . 1 - 13.
norashikin abdullah, siti shahidah sayadi, ma hanqiu, irna farhana junaidi, nur ashima ayu saturuddin, ooi theng choon, mohd hareeff muhammed, izatus shima taib, zariyantey abd hamid, nurulamin abu bakar. (2026). analytical performance verification of six emerging serum biomarkers for potential non-invasive assessment of liver fibrosis on the snibe maglumi x8 platform. - 36th macb annual conference 2026. .
nurulamin abu bakar. (2026). basic workshop on measurement uncertainty for quantitative testing: an iso 15189 perspective. - 19th asean conference of clinical laboratory sciences (accls) . .
nurulamin abu bakar. (2026). risk based quality control in medical laboratory. - kursus advance course course for risk based quality control (rbqc), kluster patologi kimia melaka. .
nurulamin abu bakar. (2026). peranan ahli sains kesihatan dalam sistem penjagaan kesihatan di malaysia (edisi 2026). - biomedical science fair 2026. .
nurulamin abu bakar, nurul izzati hamzan, siti nurwani ahmad ridzuan, izatus shima taib, zariyantey abdul hamid, anasufiza habib, noor hafizah hassan. (2026). multi-marker evaluation of creatinine, cystatin c and ß2-microglobulin for gfr estimation in stage 3–4 ckd using the 2021 ckd-epi equations. - international journal of molecular sciences . 1 - 13.
nurulamin abu bakar, and nurul izzati hamzan.. (2025). advancement in clinical glycomics and glycoproteomics for congenital disorders of glycosylation: progress and challenges ahead . - biomedicines. 1 - 18.
nurulamin abu bakar, nurul izzati hamzan, elyssa milus majawit, siti nurwani ahmad ridzuan, noor hafizah hassan, anasufiza habib, lock-hock ngu. (2025). multi-omics characterization of a novel ssr4 variant in congenital disorders of glycosylation. - metabolites. 1 - 12.
jiaxian ong, sharanya k sritharan, amar harris bin arifin, baskaran gunasekaran, rhun yian koh, nurulamin abu bakar, shamala salvamani. (2026). gas5 in colorectal cancer: a multifaceted long non-coding rna in tumor suppression, prognosis and therapeutic targeting. - advanced pharmaceutical bulletin. 221 - 234.
nurulamin abu bakar, nurul izzati hamzan, siti nurwani ahmad ridzuan, izatus shima taib, zariyantey abdul hamid, anasufiza habib, noor hafizah hassan. (2026). multi-marker evaluation of creatinine, cystatin c and ß2-microglobulin for gfr estimation in stage 3–4 ckd using the 2021 ckd-epi equations. - international journal of molecular sciences . 1 - 13.
nurulamin abu bakar, and nurul izzati hamzan.. (2025). advancement in clinical glycomics and glycoproteomics for congenital disorders of glycosylation: progress and challenges ahead . - biomedicines. 1 - 18.
nurulamin abu bakar, nurul izzati hamzan, elyssa milus majawit, siti nurwani ahmad ridzuan, noor hafizah hassan, anasufiza habib, lock-hock ngu. (2025). multi-omics characterization of a novel ssr4 variant in congenital disorders of glycosylation. - metabolites. 1 - 12.
nurulamin abu bakar. (2026). peranan ahli sains kesihatan dalam sistem penjagaan kesihatan di malaysia (edisi 2026). - biomedical science fair 2026. .
nurulamin abu bakar. (2026). pengenalan khidmat saringan kesihatan dalam risiko kesihatan. - bengkel sinergi pengajaran dan pembelajaran program sains bioperubatan sesi akademik 2025/2026. .
nurulamin abu bakar. (2025). peranan ahli sains kesihatan dalam penjagaan kesihatan di malaysia. - program dari codtis ke asiqs: membina jejak keilmuan. .
nurulamin abu bakar. (2025). penyelidikan biokimia klinikal di malaysia: apa yang boleh disumbangkan oleh ahli sains makmal perubatan?. - bengkel penyelidikan bidang kimia hayat kementerian kesihatan malaysia 2025. .
norashikin abdullah, siti shahidah sayadi, ma hanqiu, irna farhana junaidi, nur ashima ayu saturuddin, ooi theng choon, mohd hareeff muhammed, izatus shima taib, zariyantey abd hamid, nurulamin abu bakar. (2026). analytical performance verification of six emerging serum biomarkers for potential non-invasive assessment of liver fibrosis on the snibe maglumi x8 platform. - 36th macb annual conference 2026. .
nurulamin abu bakar. (2026). basic workshop on measurement uncertainty for quantitative testing: an iso 15189 perspective. - 19th asean conference of clinical laboratory sciences (accls) . .
nurulamin abu bakar. (2026). risk based quality control in medical laboratory. - kursus advance course course for risk based quality control (rbqc), kluster patologi kimia melaka. .
nurulamin abu bakar. (2026). peranan ahli sains kesihatan dalam sistem penjagaan kesihatan di malaysia (edisi 2026). - biomedical science fair 2026. .
nurulamin abu bakar. (2026). pengenalan khidmat saringan kesihatan dalam risiko kesihatan. - bengkel sinergi pengajaran dan pembelajaran program sains bioperubatan sesi akademik 2025/2026. .
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| PENGESAHAN PRESTASI DIAGNOSTIK MODEL GADA DAN ADAPTASI MODEL BARU (GADA-M) BAGI PENGESANAN AWAL KARSINOMA HEPATOSELULAR DI MALAYSIA | premier integrated labs sdn. bhd | 34.7% (2025-12-01 sehingga 2027-11-30) |
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Quality Assurance (QA) & Quality Control (QC) in Medical Laboratory
Pengalaman / Experience : 21 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Specialized Diagnostics in Chemical Pathology Laboratory
Pengalaman / Experience : 21 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Congenital Disorders of Glycosylation (CDG)
Pengalaman / Experience : 17 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Clinical Glycomics
Pengalaman / Experience : 12 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Biomarker Discovery by Omics and Bioinformatics
Pengalaman / Experience : 8 tahun/years(s)